Building a Clinically Relevant Risk Model: Predicting Risk of a Potentially Preventable Acute Care Visit for Patients Starting Antineoplastic Treatment Precision oncology depends on the matching of ...

Leading investigators in diabetes, pancreas and islet biology, and computational biology have received $12.5 million in two five-year awards from the National Institutes of Health (NIH) to create the ...

Identifying HER2 mutation, amplification, and HER2 protein overexpression as therapeutic targets in lung cancers. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...

The Union Minister of Science and Technology, Jitendra Singh, inaugurates a national conclave at IMMT, Bhubaneswar, ...

Life is all about learning. Most of us learn something new every day.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--MOMA Therapeutics, a biotechnology company focused on identifying and targeting highly dynamic, difficult to drug targets in cancer and other diseases, is pleased to ...